AquaCell has reported revenues for the three months ended December 31, 2004, on a consolidated basis, of US$111,000 as compared to US$200,000 for the similar period of the preceding year. The company said the lower revenues were primarily the result of a decrease in sales of its WST subsidiary.

Net loss on a consolidated basis, attributable to common stockholders decreased to US$864,000 or US$0.06 per share, as compared to US$1,244,000 or US$0.12 per share for the same period of the prior year.

During the six-month period, on a consolidated basis, revenues were US$310,000 as compared to US$400,000 for the similar period of the preceding year, again due primarily to a decrease in sales by the WST subsidiary.

Net loss on a consolidated basis, attributable to common stockholders, for the six months decreased to US$1,741,000 or US$0.12 per share, as compared to US$2,388,000 or US$0.24 per share for the same period of the prior year.